These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 11787528
21. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Chen X, Hale GA, Barfield R, Benaim E, Leung WH, Knowles J, Horwitz EM, Woodard P, Kasow K, Yusuf U, Behm FG, Hayden RT, Shurtleff SA, Turner V, Srivastava DK, Handgretinger R. Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105 [Abstract] [Full Text] [Related]
22. Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy. Levine JE, Uberti JP, Ayash L, Reynolds C, Ferrara JL, Silver SM, Braun T, Yanik G, Hutchinson R, Ratanatharathorn V. Biol Blood Marrow Transplant; 2003 Mar; 9(3):189-97. PubMed ID: 12652470 [Abstract] [Full Text] [Related]
23. A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. Shapira MY, Or R, Resnick IB, Bitan M, Ackerstein A, Samuel S, Elad S, Zilberman I, Miron S, Slavin S. Bone Marrow Transplant; 2003 Sep; 32(6):557-61. PubMed ID: 12953126 [Abstract] [Full Text] [Related]
24. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation. Saito T, Kanda Y, Nakai K, Kim SW, Arima F, Kami M, Tanosaki R, Tobinai K, Wakasugi H, Heike Y, Mineishi S, Takaue Y. Bone Marrow Transplant; 2003 Sep; 32(6):601-8. PubMed ID: 12953133 [Abstract] [Full Text] [Related]
25. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality. Hartwig UF, Winkelmann N, Wehler T, Kreiter S, Schneider PM, Meyer RG, Ullmann AJ, Huber C, Kolbe K, Herr W. Ann Hematol; 2005 May; 84(5):331-8. PubMed ID: 15726363 [Abstract] [Full Text] [Related]
26. Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review. Pollack SM, O'Connor TP, Hashash J, Tabbara IA. Am J Clin Oncol; 2009 Dec; 32(6):618-28. PubMed ID: 19593085 [Abstract] [Full Text] [Related]
29. Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft. Hirokawa M, Horiuchi T, Kawabata Y, Kitabayashi A, Miura AB. Bone Marrow Transplant; 2000 Jul; 26(2):177-85. PubMed ID: 10918428 [Abstract] [Full Text] [Related]
30. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Couriel DR, Saliba RM, Giralt S, Khouri I, Andersson B, de Lima M, Hosing C, Anderlini P, Donato M, Cleary K, Gajewski J, Neumann J, Ippoliti C, Rondon G, Cohen A, Champlin R. Biol Blood Marrow Transplant; 2004 Mar; 10(3):178-85. PubMed ID: 14993883 [Abstract] [Full Text] [Related]
31. Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors. Sanchez-Guijo FM, Sanchez-Abarca LI, Bueno C, Villaron E, Lopez-Holgado N, Vazquez L, Lopez-Fidalgo J, Perez-Simon JA, Caballero MD, del Cañizo MC, Orfao A, San Miguel JF. Biol Blood Marrow Transplant; 2005 May; 11(5):354-61. PubMed ID: 15846289 [Abstract] [Full Text] [Related]
32. Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease. Farag SS, Elder PJ, Marcucci G, Penza S, Mrozek E, Molina A, Lin T, Avalos BR, Copelan E. Bone Marrow Transplant; 2003 Jan; 31(2):87-93. PubMed ID: 12621488 [Abstract] [Full Text] [Related]
38. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Heinzelmann F, Lang PJ, Ottinger H, Faul C, Bethge W, Handgretinger R, Bamberg M, Belka C. Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):523-8. PubMed ID: 17869449 [Abstract] [Full Text] [Related]
39. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O. J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049 [Abstract] [Full Text] [Related]
40. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center. Ozdogu H, Boga C, Kizilkilic E, Kozanoglu I, Karakus S, Sahin FI, Unalan D, Haberal M. Transplant Proc; 2007 May 15; 39(4):1257-60. PubMed ID: 17524948 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]